Concept of globalisation undergoing transition: Uday Kotak

The way India understands self-reliance is certainly being stronger, more confident and at the same time globally engaged, Kotak added.

Reuters

September 15, 2020 / 07:20 PM IST

Uday Kotak

The concept of globalisation is undergoing a transition in a world facing the challenge of COVID-19 pandemic and self-reliance is gaining momentum, CII President Uday Kotak said on September 15.

Speaking at a virtual CII-UK Conference, he said the pandemic has changed the future of the Earth in many ways and also given an opportunity to redefine mankind.

"The concept of international cooperation or globalisation as we have known is undergoing a transition. We are moving to a definition where the concept of self-reliance is gaining momentum in the world," Uday Kotak, who is also the managing director of Kotak Mahindra Bank, said.

The way India understands self-reliance is certainly being stronger, more confident and at the same time globally engaged, he added.

At the same time, he said, the concept of financial centre of the world is undergoing a change. With Hong Kong getting aligned to China and challenges in the Middle East (Dubai), London has an opportunity to become an even stronger global financial centre for Asian markets including India, he said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show